Therapeutic Regimens and Prognostic Factors of Brain Metastatic Cancers

Song, Wen-Guang; Wang, Yi-Feng; Wang, Rui-Lin; Qu, Yin-E; Zhang, Zhi; Li, Guo-Zhong; Xiao, Ying; Fang, Fang; Chen, Hong

추천

검색

자료유형: 학술저널

저자정보: Song, Wen-Guang (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Wang, Yi-Feng (Department of Obstetrics and Gynecology, Workers' Hospital) Wang, Rui-Lin (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Qu, Yin-E (Basic Medical College, Hebei Union University) Zhang, Zhi (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Li, Guo-Zhong (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Xiao, Ying (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Fang, Fang (Department of Radiotherapy and Chemotherapy, Workers' Hospital) Chen, Hong (Department of Radiotherapy and Chemotherapy, Workers' Hospital)

저널정보: 아시아태평양암예방학회 Asian Pacific journal of cancer prevention : APJCP Asian Pacific journal of cancer prevention : APJCP 제14권 제2호

발행연도: 2013.1

수록면: 923 - 927 (5page)

이용수

📌

연구주제

📖

연구배경

🔬

연구방법

🏆

연구결과

초록· 키워드

오류제보하기

Objective: This work aims to investigate the therapeutic regimen of brain metastatic cancers and the relationship between clinical features and prognosis. Methods: Clinical data of 184 patients with brain metastatic cancers were collected and analysed for the relationship between survival time and age, gender, primary diseases, quantity of brain metastatic foci, their position, extra cranial lesions, and therapeutic regimens. Results: The average age of onset was 59.1 years old. The median survival time (MST) was 15.0 months, and the patients with breast cancer as the primary disease had the longest survival time. Females had a longer survival time than males. Patients with meningeal metastasis had extremely short survival time. Those with less than 3 brain metastatic foci survived longer than patients with more than 3. The MST of patients receiving radiotherapy only and the patients receiving chemotherapy only were all 10.0 months while the MST of patients receiving combination therapy was 16.0 months. Multiple COX regression analysis demonstrated that gender, primary diseases, and quantity of brain metastatic foci were independent prognostic factors for brain metastatic cancers. Conclusions: Chemotherapy is as important as radiotherapy in the treatment of brain metastatic cancer. Combination therapy is the best treatment mode. Male gender, brain metastatic cancers originating in the gastrointestinal tract, more than 3 metastatic foci, and involvement of meninges indicate a worse prognosis.

#Brain metastatic cancers #prognosis #treatment #radiation therapy #chemotherapy

참고문헌 (0)

참고문헌 신청

참고문헌이 DBpia에서 서비스 중이라면, [참고문헌 신청]을 통해 등록해보세요